Cargando…

Dynamic interplay of two molecular switches enabled by the MEK1/2–ERK1/2 and IL-6–STAT3 signaling axes controls epithelial cell migration in response to growth factors

Cell migration is an essential physiological process, and aberrant migration of epithelial cells underlies many pathological conditions. However, the molecular mechanisms governing cell migration are not fully understood. We report here that growth factor–induced epithelial cell migration is critica...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qin, Lyugao, Cao, Xuan, Kaneko, Tomonori, Voss, Courtney, Liu, Xuguang, Wang, Guoping, Li, Shawn S.-C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Biochemistry and Molecular Biology 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477194/ https://www.ncbi.nlm.nih.gov/pubmed/34480897 http://dx.doi.org/10.1016/j.jbc.2021.101161

Ejemplares similares

SIRT2 regulates mitochondrial dynamics and reprogramming via MEK1-ERK-DRP1 and AKT1-DRP1 axes
por: Cha, Young, et al.
Publicado: (2021)

MEK1/2 Inhibitor (GDC0623) Promotes Osteogenic Differentiation of Primary Osteoblasts Inhibited by IL-1β through the MEK-Erk1/2 and Jak/Stat3 Pathways
por: Zhang, Zeng-Qiao, et al.
Publicado: (2021)

MEK/ERK Dependent Activation of STAT1 Mediates Dasatinib-Induced Differentiation of Acute Myeloid Leukemia
por: Fang, Yanfen, et al.
Publicado: (2013)

A phosphorylation switch controls the spatiotemporal activation of Rho GTPases in directional cell migration
por: Cao, Xuan, et al.
Publicado: (2015)

Cyclic tensile force modifies calvarial osteoblast function via the interplay between ERK1/2 and STAT3
por: Xiao, Xiaoyue, et al.
Publicado: (2023)

Deregulation of Hepatic Mek1/2–Erk1/2 Signaling Module in Iron Overload Conditions
por: Tangudu, Naveen Kumar, et al.
Publicado: (2019)

Erratum: A phosphorylation switch controls the spatiotemporal activation of Rho GTPases in directional cell migration
por: Cao, Xuan, et al.
Publicado: (2015)

MEK reduces cancer-specific PpIX accumulation through the RSK-ABCB1 and HIF-1α-FECH axes
por: Chelakkot, Vipin Shankar, et al.
Publicado: (2020)

The Effect of Arrestin Conformation on the Recruitment of c-Raf1, MEK1, and ERK1/2 Activation
por: Coffa, Sergio, et al.
Publicado: (2011)

MEK inhibition induces apoptosis in osteosarcoma cells with constitutive ERK1/2 phosphorylation
por: Baranski, Zuzanna, et al.
Publicado: (2015)

Cardiac Hormones Target the Ras-MEK 1/2-ERK 1/2 Kinase Cancer Signaling Pathways
por: Vesely, David L.
Publicado: (2011)

The MAPK MEK1/2-ERK1/2 Pathway and Its Implication in Hepatocyte Cell Cycle Control
por: Guégan, Jean-Philippe, et al.
Publicado: (2012)

The MEK-ERK Pathway Is Necessary for Serine Phosphorylation of Mitochondrial STAT3 and Ras-Mediated Transformation
por: Gough, Daniel J., et al.
Publicado: (2013)

IKBKE-driven TPL2 and MEK1 phosphorylations sustain constitutive ERK1/2 activation in tumor cells
por: Göktuna, Serkan Ismail
Publicado: (2022)

Crocetin protects against cardiac hypertrophy by blocking MEK-ERK1/2 signalling pathway
por: Cai, Jun, et al.
Publicado: (2010)

Crocetin protects against cardiac hypertrophy by blocking MEK-ERK1/2 signalling pathway
por: Cai, Jun, et al.
Publicado: (2009)

ERK1b, a 46‐kDa ERK isoform that is differentially regulated by MEK
por: Yung, Yuval, et al.
Publicado: (2022)

The D Domain of LRRC4 anchors ERK1/2 in the cytoplasm and competitively inhibits MEK/ERK activation in glioma cells
por: Wang, Zeyou, et al.
Publicado: (2016)

Correction: The MEK-ERK Pathway Is Necessary for Serine Phosphorylation of Mitochondrial STAT3 and Ras-Mediated Transformation
por: Gough, Daniel J., et al.
Publicado: (2013)

Blocking STAT3 signaling augments MEK/ERK inhibitor efficacy in esophageal squamous cell carcinoma
por: Zheng, Zhen-Yuan, et al.
Publicado: (2022)

Interplay between MEK-ERK signaling, cyclin D1, and cyclin-dependent kinase 5 regulates cell cycle reentry and apoptosis of neurons
por: Modi, Prashant Kumar, et al.
Publicado: (2012)

Mek1 and Mek2 Functional Redundancy in Erythropoiesis
por: Beuret, Laurent, et al.
Publicado: (2021)

Dehydrocorydaline inhibits cell proliferation, migration and invasion via suppressing MEK1/2-ERK1/2 cascade in melanoma
por: Hu, Huanrong, et al.
Publicado: (2019)

Galangin ameliorates cardiac remodeling via the MEK1/2–ERK1/2 and PI3K–AKT pathways
por: Wang, Hui‐Bo, et al.
Publicado: (2019)

Playing the Whack-A-Mole Game: ERK5 Activation Emerges Among the Resistance Mechanisms to RAF-MEK1/2-ERK1/2- Targeted Therapy
por: Tubita, Alessandro, et al.
Publicado: (2021)

The MEK1/2-ERK Pathway Inhibits Type I IFN Production in Plasmacytoid Dendritic Cells
por: Janovec, Vaclav, et al.
Publicado: (2018)

Merkel cell polyomavirus–negative Merkel cell carcinoma is associated with JAK‐STAT and MEK‐ERK pathway activation
por: Iwasaki, Takeshi, et al.
Publicado: (2021)

Combining radiotherapy with MEK1/2, STAT5 or STAT6 inhibition reduces survival of head and neck cancer lines
por: Stegeman, Hanneke, et al.
Publicado: (2013)

Radiation-Induced c-Jun Activation Depends on MEK1-ERK1/2 Signaling Pathway in Microglial Cells
por: Deng, Zhiyong, et al.
Publicado: (2012)

Cardiac glycoside/aglycones inhibit HIV-1 gene expression by a mechanism requiring MEK1/2-ERK1/2 signaling
por: Wong, Raymond W., et al.
Publicado: (2018)

UBTF facilitates melanoma progression via modulating MEK1/2-ERK1/2 signalling pathways by promoting GIT1 transcription
por: Zhang, Jian, et al.
Publicado: (2021)

FLOT2 Promotes the Proliferation and Epithelial-mesenchymal Transition of Cervical Cancer by Activating the MEK/ERK1/2 Pathway
por: Li, Yang, et al.
Publicado: (2022)

The Chemokine CCL4 Stimulates Angiopoietin-2 Expression and Angiogenesis via the MEK/ERK/STAT3 Pathway in Oral Squamous Cell Carcinoma
por: Lu, Chien-Chi, et al.
Publicado: (2022)

Activation of MEK1/2‐ERK1/2 signaling during NNK‐induced lung carcinogenesis in female A/J mice
por: Yamakawa, Keiko, et al.
Publicado: (2016)

Dehydrocorydaline Inhibits Cell Proliferation, Migration and Invasion via Suppressing MEK1/2-ERK1/2 Cascade in Melanoma [Corrigendum]
Publicado: (2021)

MEK/ERK addiction in CNL/aCML
por: Kesarwani, Meenu, et al.
Publicado: (2017)

Netrin-1 suppresses the MEK/ERK pathway and ITGB4 in pancreatic cancer
por: An, Xi-Zhou, et al.
Publicado: (2016)

Rigosertib inhibits MEK1–ERK pathway and alleviates lipopolysaccharide‐induced sepsis
por: Wang, Yin, et al.
Publicado: (2021)

HA Triggers the Switch from MEK1 SUMOylation to Phosphorylation of the ERK Pathway in Influenza A Virus-Infected Cells and Facilitates Its Infection
por: Wang, Chengmin, et al.
Publicado: (2017)

Protein phosphatase 6 regulates trametinib sensitivity, a mitogen-activated protein kinase kinase (MEK) inhibitor, by regulating MEK1/2-ERK1/2 signaling in canine melanoma cells
por: YAMAMOTO, Miu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_641qjs8eut8u9ambgl8hgkugm9